封面
市場調查報告書
商品編碼
1566169

診斷心電圖機市場規模、佔有率、成長分析、按產品類型、按引線類型、按最終用戶、按地區 - 行業預測,2024-2031 年

Diagnostic Electrocardiograph Market Size, Share, Growth Analysis, By Product, By Lead Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 270 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球診斷心電圖機市場規模為76億美元,從2023年的81.3億美元成長到2031年的138.9億美元,在預測期內(2024-2031年)預計複合年成長率為6.12%。

在消費者生活方式改變和缺血性心臟疾病、高血壓心臟疾病和周圍性心臟疾病等心血管疾病患病率上升的推動下,全球診斷心電圖(ECG)市場預計將顯著成長。除了全球老年人口不斷成長之外,醫療基礎設施的進步和有利的報銷政策也進一步支持了這一成長。此外,心電圖設備技術創新的不斷增加和遠端監控解決方案的出現也增加了市場的活力。特別是,在醫療保健支出增加和使用率不足的推動下,新興市場預計將比已開發市場成長更快。一個典型的例子是 Qpatch,一款由 Medicalgorithmics 開發的先進心電圖穿戴式設備,於 2022 年 6 月獲得美國食品藥物管理局的核准。特別是美國的市場狀況預計將在預測期內保持健康的複合年成長率,反映出不斷發展的醫療保健領域對先進診斷解決方案的強勁需求。隨著這些趨勢的持續發展,受益於技術進步和消費者健康意識的提高,心電圖儀市場將持續成長。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 二手資料來源和主要資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 價格分析
  • 專利分析
  • 價值鏈分析
  • 供應鏈分析
  • 監管環境
  • 貿易分析
  • 技術分析
  • 客戶和購買標準分析

診斷心電圖機市場:依產品分類

  • 市場概況
  • 裝置
    • 靜態心電圖儀
    • 負荷心電圖儀
    • 心電圖監測
    • 心臟事件記錄器
    • 嵌入式循環錄音機
    • 移動心臟遠端檢測裝置
    • 智慧型心電監視器
  • 軟體和服務

依導極類型分類的診斷心電圖機市場

  • 市場概況
  • 12導聯心電圖儀
  • 5導聯心電圖儀
  • 3導聯心電圖裝置
  • 6導聯心電圖儀
  • 單導程心電圖裝置
  • 其他CG設備

診斷心電圖機市場:依最終用戶分類

  • 市場概況
  • 醫院、診所、心臟中心
  • 門診手術中心
  • 其他最終用戶

診斷心電圖機市場:按地區分類的規模

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率(2023年)

主要企業簡介

  • General Electric
  • Koninklijke Philips NV
  • Baxter International Inc.
  • Fukuda Denshi
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • BPL Medical Technologies
  • Schiller Ag
  • Bittium
  • ACS Diagnostics
  • Allengers Medical Systems Ltd.
  • Bionet
  • Cardiac Insight, Inc.
  • BTL
  • Meditech Equipment Co. Ltd.
  • Midmark Corporation
  • AliveCor, Inc.
  • Vitalconnect
  • Vectracor
  • iRhythm Technologies, Inc.
  • Borsam Biomedical Instruments Co., Ltd.
  • Nasiff Associates, Inc.
  • Biomedical Instruments Co. Ltd.
  • LifeSignals, Inc.
簡介目錄
Product Code: SQMIG35A2621

Global Diagnostic Electrocardiograph Market size was valued at USD 7.60 billion in 2022 and is poised to grow from USD 8.13 billion in 2023 to USD 13.89 billion by 2031, growing at a CAGR of 6.12% during the forecast period (2024-2031).

The global diagnostic electrocardiograph (ECG) market is poised for significant growth, driven by shifting consumer lifestyles and the rising prevalence of cardiovascular diseases such as ischemic heart disease, hypertensive heart disease, and peripheral heart disease. This growth is further supported by advancements in healthcare infrastructure and favorable reimbursement policies, alongside an increasing elderly population worldwide. Additionally, ongoing technological innovations in ECG devices and the emergence of remote monitoring solutions are enhancing market dynamics. Notably, developing regions are expected to experience accelerated growth compared to their developed counterparts, fueled by rising healthcare expenditure and the opportunity to tap into underutilized markets. A prime example is the June 2022 approval by the U.S. Food and Drug Administration of Qpatch, an advanced ECG wearable device created by Medicalgorithmics, which enables precise cardiac arrhythmia diagnosis through real-time ECG signal measurements. In particular, the U.S. diagnostic electrocardiograph market is projected to maintain a healthy compound annual growth rate (CAGR) in the forthcoming forecast period, reflecting a robust demand for advanced diagnostic solutions in the evolving healthcare landscape. As these trends continue to unfold, the ECG market stands to benefit from both technological advancements and increasing health awareness among consumers, positioning it for sustained growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diagnostic Electrocardiograph market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diagnostic Electrocardiograph Market Segmental Analysis

Global Diagnostic Electrocardiograph Market is segmented by Product, Lead Type, End User, and Region. Based on Product, the market is segmented into Devices (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Smart ECG Monitors), Software & Services. Based on Lead Type, the market is segmented into 12-Lead ECG Devices, 5-Lead ECG Devices, 3-Lead ECG Devices, 6-Lead ECG Devices, Single-Lead ECG Devices, Other ECG Lead Devices. Based on End User, the market is segmented into Hospitals, Clinics, And Cardiac Centers, Ambulatory Surgery Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diagnostic Electrocardiograph Market

The global diagnostic electrocardiograph (ECG) market is poised for significant growth, propelled by an aging population that is increasingly vulnerable to cardiovascular diseases and heightened consumer awareness regarding non-invasive diagnostic options. The surge in chronic heart disease prevalence, especially in Western nations attributed to unhealthy lifestyles and dietary habits, further underscores the demand for effective cardiac monitoring solutions. With a staggering 850,000 heart attacks occurring annually in the United States alone, including approximately 605,000 first-time incidents, healthcare providers are likely to invest more in ECG technologies to enhance patient care, thereby driving market expansion over the forecast period.

Restraints in the Global Diagnostic Electrocardiograph Market

The global diagnostic electrocardiograph (ECG) market faces significant restraints, primarily due to a lack of awareness about the importance and benefits of ECG in diagnosing cardiovascular diseases. This knowledge gap among healthcare professionals and patients limits the adoption of ECG technology, inhibiting market growth. Additionally, the shortage of skilled technicians and healthcare providers trained in using and interpreting ECG results poses a critical barrier to expanding its usage and improving diagnostic accuracy. These combined factors lead to underutilization of ECG devices, ultimately restraining the market's potential development and hindering access to timely and effective cardiovascular care.

Market Trends of the Global Diagnostic Electrocardiograph Market

The global diagnostic electrocardiograph market is witnessing a significant trend towards the adoption of advanced portable and compact Holter ECG devices, particularly within the home healthcare segment. These innovations offer numerous advantages, including enhanced accessibility and convenience for patients, driving their popularity. Additionally, the surge in collaborations among manufacturers to improve technology and service offerings is further propelling market growth. This confluence of factors is setting a favorable landscape for the Holter ECG market, indicating robust expansion opportunities as healthcare systems adapt to meet the rising demand for remote cardiac monitoring solutions, particularly post-pandemic.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Pricing Analysis
  • Patent Analysis
  • Value Chain Analysis
  • Supply Chain Analysis
  • Regulatory Landscape
  • Trade Analysis
  • Technology Analysis
  • Customer & Buying Criteria Analysis

Diagnostic Electrocardiograph Market, By Product

  • Market Overview
  • Devices
    • Resting ECG Devices
    • Stress ECG Devices
    • Holter Monitors
    • Event Monitors
    • Implantable Loop Recorders
    • Mobile Cardiac Telemetry Devices
    • Smart ECG Monitors
  • Software & Services

Diagnostic Electrocardiograph Market, By Lead Type

  • Market Overview
  • 12-Lead ECG Devices
  • 5-Lead ECG Devices
  • 3-Lead ECG Devices
  • 6-Lead ECG Devices
  • Single-Lead ECG Devices
  • Other ECG Lead Devices

Diagnostic Electrocardiograph Market, By End User

  • Market Overview
  • Hospitals, Clinics, And Cardiac Centers
  • Ambulatory Surgery Centers
  • Other End Users

Diagnostic Electrocardiograph Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • General Electric
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fukuda Denshi
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical International Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nihon Kohden Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BPL Medical Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Schiller Ag
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bittium
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ACS Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allengers Medical Systems Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bionet
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiac Insight, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BTL
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meditech Equipment Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Midmark Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AliveCor, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitalconnect
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vectracor
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iRhythm Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Borsam Biomedical Instruments Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nasiff Associates, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomedical Instruments Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeSignals, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments